Abstract
Background: The goal is to introduce visual performance mapping efficient for establishing acceptance criteria and facilitating decisions regarding the utility of hospital point-of-care devices. This approach uniquely reveals the quality of performance locally, as opposed to globally.
Methods: After presenting theoretical foundations, this study illustrates the approach by applying it to six hospital glucose meter systems (GMSs) using clinical multi-center (n=2767) and multi-system (n=613, n=100) observations.
Results: LS MAD curves identified breakouts, that is, points where the locally-smoothed median absolute difference (LS MAD) curve exceeds the recommended error tolerance limit of 5 mg/dL (0.28 mmol/L). LS maximum absolute difference (MaxAD) breakthroughs, which occur where the LS MaxAD curve exceeds the 99th percentile of MaxADs from x=30–200 mg/dL (1.67–11.10 mmol/L), showed extreme error locations. A multi-sensor interference- and hematocrirt-correcting GMS displayed a flat LS MAD curve until it reached a breakout of 179 mg/dL (9.94 mmol/L) and generated breakthroughs that could affect bedside decision-making, but less erratically than other systems with inadequate performance for hospital critical care. We discovered Class I (meter high, reference low) and Class II (converse) discrepant values in some systems. Class I errors could lead to inappropriate insulin dosing and hypoglycemic episodes in tight glucose control.
Conclusions: LS MAD-MaxAD curves help assess the performance of point-of-care testing. Visual mapping of systematic and random errors locally over the entire analyte measurement range in a single integrated display is an advantage when considering the adverse impact of zones of poor quantitative performance on specific clinical applications, threshold-driven bedside decisions and the care of critically ill patients.
©2011 by Walter de Gruyter Berlin Boston
Articles in the same Issue
- Editorial
- Laboratory medicine: an essential partner in the care of cancer patients
- Reviews
- Circulating tumor cells as emerging tumor biomarkers in breast cancer
- Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer
- Increased plasma concentrations of tumour markers in the absence of neoplasia
- Recent progress and clinical importance on pharmacogenetics in cancer therapy
- Genetics and Molecular Diagnostics
- Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000® instrument
- General Clinical Chemistry and Laboratory Medicine
- Mapping point-of-care performance using locally-smoothed median and maximum absolute difference curves
- The use of inflammatory markers as a method for discharging patients post hip or knee arthroplasty
- Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease
- Combined effects of coffee consumption and serum γ-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women
- Multicentre comparison of free thyroid hormones immunoassays: the Immunocheck study
- Comparative evaluation of capillary zone electrophoresis and HPLC in the determination of carbohydrate-deficient transferrin
- Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects
- Analytical performance of a multiplexed, bead-based cytokine detection system in small volume samples
- Diagnostic utility of a soluble cytokeratin 18 assay for gastrointestinal graft-vs.-host disease detection
- Cancer Diagnostics
- The correlation between zinc and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and prostate-specific antigen (PSA) in prostate cancer
- Differential expression of CDC25 phosphatases splice variants in human breast cancer cells
- Serum APRIL, a potential tumor marker in pancreatic cancer
- Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
- Infectious Diseases
- New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
- Cardiovascular Diseases
- Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese Population
- Diabetes
- Glycated albumin may be a possible alternative to hemoglobin A1c in diabetic patients with anemia
- A simple micro-photometric method for urinary iodine determination
- Letters to the Editor
- Clinically needed sensitivity for very low levels of Factor XIII: not yet proven for a new functional assay
- Apolipoprotein A5-12238 T>C gene polymorphism and risk factors for metabolic syndrome in the Guo Shan Yao and the Han populations
- Congress Abstracts
- 10.1515/CCLM.2011.738
- 1st National Congress of Laboratory Medicine
Articles in the same Issue
- Editorial
- Laboratory medicine: an essential partner in the care of cancer patients
- Reviews
- Circulating tumor cells as emerging tumor biomarkers in breast cancer
- Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer
- Increased plasma concentrations of tumour markers in the absence of neoplasia
- Recent progress and clinical importance on pharmacogenetics in cancer therapy
- Genetics and Molecular Diagnostics
- Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000® instrument
- General Clinical Chemistry and Laboratory Medicine
- Mapping point-of-care performance using locally-smoothed median and maximum absolute difference curves
- The use of inflammatory markers as a method for discharging patients post hip or knee arthroplasty
- Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease
- Combined effects of coffee consumption and serum γ-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women
- Multicentre comparison of free thyroid hormones immunoassays: the Immunocheck study
- Comparative evaluation of capillary zone electrophoresis and HPLC in the determination of carbohydrate-deficient transferrin
- Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects
- Analytical performance of a multiplexed, bead-based cytokine detection system in small volume samples
- Diagnostic utility of a soluble cytokeratin 18 assay for gastrointestinal graft-vs.-host disease detection
- Cancer Diagnostics
- The correlation between zinc and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and prostate-specific antigen (PSA) in prostate cancer
- Differential expression of CDC25 phosphatases splice variants in human breast cancer cells
- Serum APRIL, a potential tumor marker in pancreatic cancer
- Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
- Infectious Diseases
- New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
- Cardiovascular Diseases
- Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese Population
- Diabetes
- Glycated albumin may be a possible alternative to hemoglobin A1c in diabetic patients with anemia
- A simple micro-photometric method for urinary iodine determination
- Letters to the Editor
- Clinically needed sensitivity for very low levels of Factor XIII: not yet proven for a new functional assay
- Apolipoprotein A5-12238 T>C gene polymorphism and risk factors for metabolic syndrome in the Guo Shan Yao and the Han populations
- Congress Abstracts
- 10.1515/CCLM.2011.738
- 1st National Congress of Laboratory Medicine